Raymond Cheong
Director/Board Member bij TALIS BIOMEDICAL CORPORATION
Vermogen: - $ op 31-03-2024
Profiel
Raymond Cheong is currently a Director at Madrigal Pharmaceuticals, Inc., Istari Oncology, Inc., Talis Biomedical Corp., and vTv Therapeutics, Inc. He previously worked as a Director at Talis Biomedical Corp.
Dr. Cheong holds a doctorate degree from The Johns Hopkins University and an undergraduate degree from the University of Maryland.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TALIS BIOMEDICAL CORP.
-.--% | 31-01-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Raymond Cheong
| Bedrijven | Functie | Begin |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 10-03-2023 |
| MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 15-06-2023 |
| VTV THERAPEUTICS INC. | Director/Board Member | 27-02-2024 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 01-12-2018 |
Eerdere bekende functies van Raymond Cheong
| Bedrijven | Functie | Einde |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 10-06-2022 |
Opleiding van Raymond Cheong
| The Johns Hopkins University | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VTV THERAPEUTICS INC. | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
| Talis Biomedical Corp. |
